DOH Home  >>  Press Releases
 
PO Box 360
Trenton, NJ 08625-0360

For Release:
May 18, 2006

Fred M. Jacobs, M.D., J.D.
Commissioner

For Further Information Contact:
Marilyn Riley
(609) 984-7160


 
DHSS Sponsors May 24 Conference on HPV Vaccine to Prevent Cervical Cancer


 

          TRENTON – About 300 health care professionals are expected to attend the May 24 conference, “Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Cancer:  Scientific and Implementation Issues,” sponsored by the New Jersey Department of Health and Senior Services.

          The conference features speakers and panel discussions on the proposed new HPV vaccine, the first vaccine being considered for U.S. Food and Drug Administration approval for primary prevention of a type of cancer.

Among those attending the conference will be physicians, nurses, school nurses, public health professionals, and professionals in community health organizations focused on family planning, cancer, HIV and related issues.  The conference runs from 8:45 a.m. to 3:30 p.m. at the Crowne Plaza Hotel, 390 Forsgate Drive, Jamesburg, NJ.

Two manufacturers currently are seeking FDA approval for a vaccine against HPV viruses that cause most cases of cervical cancer and genital warts.  Worldwide, cervical cancer is the second most common cause of cancer death in women.  Nationwide, about 10,000 cervical cancer cases were diagnosed in 2005 and about 3,700 women died.

Featured speakers at the DHSS conference include:

  • Dr. Eddy Bresnitz, the department’s State Epidemiologist and Deputy Commissioner, who will discuss the epidemiology of cervical cancer in New Jersey and the state’s cervical cancer screening program.
  • Dr. Eileen Dunne, of the federal Centers for Disease Control and Prevention, who will discuss HPV vaccine research and clinical trials, and the efficacy of the vaccine in reducing cervical cancer.
  • Dr. Charles Scott, a New Jersey pediatrician, who will talk about the challenges of providing the vaccine in a clinical practice.
  • T. Patrick Hill, Ph.D., of Rutgers – The State University of New Jersey, who will discuss ethical issues in implementing a vaccination program.

Two panel discussions will focus on regulatory and insurance issues in providing HPV vaccine, and education and communication issues in encouraging use of the vaccine.  Panel members include parents, physicians, and representatives of the insurance industry and the New Jersey Department of Education.

# # #

 
 
Previous Screen

 

Department of Health

P. O. Box 360, Trenton, NJ 08625-0360
Our Locations
Privacy policy, terms of use and contact form links State Privacy Notice legal statement DOH Feedback Page New Jersey Home


OPRA- Open Public RecordAct
department: njdoh home | index by topic | programs/services
statewide:njhome | services A to Z  | Departments/Agencies | FAQs
Copyright © State of New Jersey, 1996-